Natco Pharma Ltd (NATCOPHARM) Shareholding Pattern - Promoter, FII, DII & Public Holdings
As of Jun 2026, promoters held 49.41% of Natco Pharma Ltd, FIIs 16.99%, DIIs 5.63%, government - and the public 27.97%, across 4,03,166 shareholders.
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 49.62% | 49.62% | 49.56% | 49.56% | 49.48% | 49.48% | 49.41% | 49.41% |
| FIIs | 17.51% | 17.94% | 17.49% | 15.52% | 14.09% | 15.16% | 17.37% | 16.99% |
| DIIs | 6.75% | 5.59% | 5.64% | 5.81% | 5.87% | 5.39% | 5.46% | 5.63% |
| Public | 26.13% | 26.88% | 27.3% | 29.12% | 30.56% | 29.97% | 27.74% | 27.97% |
| No. of Shareholders | 3,02,944 | 3,45,332 | 4,05,222 | 4,29,434 | 4,19,699 | 4,24,167 | 4,10,970 | 4,03,166 |